Effect of N-Feruloylserotonin and Methotrexate on Severity of Experimental Arthritis and on Messenger RNA Expression of Key Proinflammatory Markers in Liver

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Compound</td><td class="align_center">Content [%]</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">N-(E)-Feruloylserotonin</td><td class="align_center">18.3</td></tr><tr><td class="align_left">N-(E)-Isoferuloylserotonin</td><td class="align_center">67.4</td></tr><tr><td class="align_left">N-(Z)-Feruloylserotonin</td><td class="align_center">6.1</td></tr><tr><td class="align_left">N-(Z) Isoferuloylserotonin</td><td class="align_center">8.2</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Composition of the crystalline N-feruloylserotonin complex fraction, where the content of N-feruloyl- and N-isoferuloyl- (E = trans- and Z = cis-) serotonin isomers was determined by HPLC analysis. 

Journal of Immunology Research

tab1

Table 1

Table 1: Effect of N-Feruloylserotonin and Methotrexate on Severity of Experimental Arthritis and on Messenger RNA Expression of Key Proinflammatory Markers in Liver 

Table 1 | Effect of N-Feruloylserotonin and Methotrexate on Severity of Experimental Arthritis and on Messenger RNA Expression of Key Proinflammatory Markers in Liver 